-+ 0.00%
-+ 0.00%
-+ 0.00%
Wiley Partners With Abridge to Integrate Cochrane Evidence Into Clinical AI Assistant
Share
Listen to the news
Wiley Partners With Abridge to Integrate Cochrane Evidence Into Clinical AI Assistant
  • Wiley entered a multiyear partnership with Abridge to integrate Cochrane evidence into the Abridge Assistant for US care-delivery organizations.
  • The licensing agreement covers nearly 10,000 systematic reviews and about 4,000 clinical answers for clinical decision support.
  • Evidence will appear as concise, cited summaries, with full text accessible to Wiley subscribers.
  • Abridge serves more than 300 US health systems and expects to support more than 120 million patient encounters this year.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. John Wiley & Sons Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261116095169) on November 16, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending